Julie E Chang
Impact in
-
- Lymphoma Diagnosis and Treatment
- Genetics top 2%
- Chronic Lymphocytic Leukemia Research
- Glioma Diagnosis and Treatment
Papers in
-
- Lymphoma Diagnosis and Treatment 28
- Genetics 16
- Chronic Lymphocytic Leukemia Research 13
- Co-authors
- H. Ian Robins (2 shared papers)Minesh P. Mehta (2 shared papers)Brad S. Kahl (13 shared papers)Deepak Khuntia (1 shared paper)John M. Burke (3 shared papers)Ian W. Flinn (3 shared papers)Samar Issa (3 shared papers)Judith Trotman (3 shared papers)
- Journals
- Blood (16 papers)Journal of the National Comprehensive Cancer Network (4 papers)Journal of Clinical Oncology (2 papers)Blood Advances (2 papers)Clinical Cancer Research (2 papers)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Julie E Chang
46 papers receiving 2.2k citations
Julie E Chang's Hit Papers
Peers
Comparison fields: 5 of 90
- Pathology and Forensic Medicine 1.2k
- Genetics 674
- Oncology 881
- Neurology 272
- Cancer Research 157
Countries citing papers authored by Julie E Chang
This map shows the geographic impact of Julie E Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie E Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie E Chang more than expected).
Fields of papers citing papers by Julie E Chang
This network shows the impact of papers produced by Julie E Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie E Chang. The network helps show where Julie E Chang may publish in the future.
Co-authors
The 25 scholars most cited alongside Julie E Chang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dose-Adjusted EPOCH-R Compared With R-CHOP as Frontline Therapy for Diffuse Large B-Cell Lymphoma: Clinical Outcomes of the Phase III Intergroup Trial Alliance/CALGB 50303 Hit paper breakdown → | 2019 | 324 |
| 2 | 2011 | 323 | |
| 3 | Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation Hit paper breakdown → | 2023 | 239 |
| 4 | 2019 | 226 | |
| 5 | 2019 | 146 | |
| 6 | 2021 | 116 | |
| 7 | 2013 | 111 | |
| 8 | 2016 | 91 | |
| 9 | Radiotherapy and radiosensitizers in the treatment of glioblastoma multiforme. | 2007 | 82 |
| 10 | 2011 | 81 | |
| 11 | 2023 | 79 | |
| 12 | Therapeutic advances in the treatment of brain metastases. | 2007 | 42 |
| 13 | 2008 | 42 | |
| 14 | 2014 | 37 | |
| 15 | 2021 | 29 | |
| 16 | 2011 | 22 | |
| 17 | 2015 | 22 | |
| 18 | 2023 | 21 | |
| 19 | 2011 | 20 | |
| 20 | 2023 | 19 |
About Julie E Chang
Julie E Chang is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Neurology and Pulmonary and Respiratory Medicine, having authored 46 papers that have together received 2.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (28 papers), Chronic Lymphocytic Leukemia Research (13 papers), CNS Lymphoma Diagnosis and Treatment (6 papers), CAR-T cell therapy research (5 papers), Viral-associated cancers and disorders (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), HER2/EGFR in Cancer Research (4 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Pathology and Forensic Medicine (1.2k citations), Genetics (674 citations), Oncology (881 citations), Neurology (272 citations) and Cancer Research (157 citations). Julie E Chang has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include H. Ian Robins, Minesh P. Mehta, Brad S. Kahl, Deepak Khuntia, John M. Burke, Ian W. Flinn, Samar Issa, Judith Trotman, Kathryn S. Kolibaba and Patrick Wood. Their work appears in journals such as Blood, Journal of the National Comprehensive Cancer Network, Journal of Clinical Oncology, Blood Advances and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.